FDA and EMA release collaborative AI framework for drug development

"FDA and EMA release collaborative AI framework for drug development" was originally created and published by Clinical Trials ...

US, European regulators set principles for 'good AI practice' in drug development

The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible ...
BioWorld

EFPIA calls for EMA to oversee AI in drug development

Just ahead of the EMA setting out its latest thinking on regulation in the new era of artificial intelligence (AI), the industry has put forward its position on how to ensure AI rules enable, rather ...
Medscape

From Diabetes to Duchenne: EMA’s Defining 2025 Drug Calls

The European regulator’s anniversary year featured first-in-class therapies, rare-disease advances, safety warnings, and new ...

The AI drug breakthrough is taking a long time to arrive for reasons that may have little to do with the technology’s limits

It wasn’t always this way. Leveraging AI in drug development is not only thanks to growing access to semiconductor chips, but ...